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Abstract IL-6 is a biologically active cytokine released
during exercise by contracting skeletal muscles. It appears
to be highly involved in the regulation of muscles energy
substrate utilization. Whether an ablation of IL-6 (IL-6
KO) in mice subjected to a single bout of exercise affects
lipid and/or glucose metabolism is currently unknown. In
the present study we examined fatty acid (FAT/CD36,
FABPpm, FATP-1, FATP-4) as well as glucose (GLUT-1,
GLUT-4) transporters expression in IL-6 KO mice. In
addition, intramuscular glycogen and lipid content was also
evaluated. The expression of all fatty acid transporters
(FAT/CD36: ?25 %; FATP-1: ?31 %; FABPpm:
?12.7 %; FATP-4: ?7.2 %) was increased in muscles
from IL-6 KO mice compared to wild type (WT) mice.
Accordingly intramuscular lipid content was also increased
in these muscles (FFA: ?38 %; DAG: ?36 % and TAG:
?160 %). Interestingly, IL-6 deficiency had only minor
effect on glucose transporters expression (GLUT-1: -4 %,
and GLUT-4: -5.1 %), with no apparent difference in
muscular glycogen content. A single bout of exercise
increased the glucose transporters (GLUT-1: ?8 %;
GLUT-4: ?15 %) as well as FA transporters (FAT/CD36:
?13 %; FABPpm: ?4.5 %; FATP: ?2.5 %, FATP-4:
?10 %) expression but only in WT skeletal muscles. In
muscles from IL-6 KO mice exercise induced changes only
in glucose (GLUT-1: ?20 %; GLUT-4: ?35 %) but not in
the content of FA transporters. Concomitantly, IL-6 KO
mice displayed shorter time toward exhaustion with more
pronounced reductions in intramuscular lipid and glycogen
content. We may speculate, that IL-6 deficiency provokes
more pronounced glucose utilization over lipid oxidation
during a single bout of exhausting exercise.
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FABPpm Plasma membrane associated fatty acid
binding protein
FAT/CD36 Fatty acid translocase
FATP-1 Fatty acid transport protein isoform 1
FATP-4 Fatty acid transport protein isoform 4
FFA Free fatty acids
GLUT-1 Glucose transporter isoform 1
GLUT-4 Glucose transporter isoform 2
IL-6 Interleukin-6
KO Knock-out animals
PCR Polymerase chain reaction
SEM Standard error of the mean
SOCS Suppressor of cytokine signaling
TAG Triacylglycerols
WT Wild type animals
Introduction
In the last few years, evidence has accumulated showing
that interleukin-6 (IL-6) is an important molecule involved
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not only in immune regulation, hematopoiesis or inflam-
mation but also in glucose and lipid metabolism [1]. IL-6 is
synthesized by skeletal muscle and its secretion is mark-
edly augmented during contractile activity [1, 2]. The
resultant increase in IL-6 serum concentration positively
correlates with increased glucose uptake and fatty acid
(FA) oxidation in skeletal muscles. Likely both seem to be
mediated by activation of AMPK (AMP-activated protein
kinase) [1, 3, 4]. The activation of AMPK, which increases
usage of energy substrates is commonly implicated in
insulin sensitizing actions in skeletal muscles. However,
this view has been recently challenged since serum IL-6
elevation was commonly observed in patients with meta-
bolic disorders such as obesity and/or diabetes [5–7]. There
is no evident explanation for this discrepancy. It might be
speculated that IL-6 is also a potent activator of SOCS
(suppressor of cytokine signaling) and thus increased
activation of SOCS3 in skeletal muscles and liver leads to
insulin resistance commonly observed in patients with
obesity and diabetes [8].
At rest, skeletal muscles use both glucose and fatty acids
(FA) as an equivalent energy source [9, 10]. However
during exercise, the type of substrate used depends mainly
on the intensity and the duration of exercise [2, 11]. It is
generally well accepted that, with increased intensity of the
exercise, there is a substantial enhancement in glucose
utilization. Importantly, a crucial (but not exclusive) rate-
limiting process in myocytes glucose utilization, involves
transport of glucose across the sarcolemma. The process,
that is specifically mediated by membrane glucose trans-
porter proteins belonging to the facilitative GLUT/SLC2A
family [12]. In contrary, fatty acids (FA), due to their
hydrophobic nature, are able to rapidly traverse the lipid
bilayer of the cell membrane by simple diffusion [13].
However, in addition to passive diffusion, a considerable
evidence has accumulated to support the existence and
importance of a protein-mediated FA transport [14–16]. In
skeletal muscles a number of FA transporters have been
identified, including (1) a family of fatty acid transport
proteins (i.e. FATP-1,4), (2) plasma membrane associated
fatty acid binding protein (FABPpm) and (3) fatty acid
translocase (FAT/CD36) [17–19].
Given that IL-6 is an important muscle derived factor
highly involved in myocyte energy substrate metabolism,
we sought to investigate the effect of IL-6 ablation on
glucose (GLUT-1, 4) and FA transporters (FAT/CD36,
FABPpm, FATP-1,4) expression in skeletal muscle chal-
lenged by exercise. Additionally, intramuscular lipids and
the glycogen contents were assessed. Aware of the age
influence in IL-6 KO phenotype, we investigated the effect
of a single bout of exhausting exercise in older mice
(12 months).
Materials and Methods
Animals and Experimental Model
Male mice, wild type (C57B4/6J) and IL-6 KO (C57B4/6J
IL-6tml Kopf-/-) were randomly allocated into two groups:
sedentary and exercised till exhaustion (swimming). Until
the day of experiment (12 months) mice were bred on site
in an approved animal holding facility with free access to
food and water. The study was conducted in accordance to
guidelines of local ethic committee for animal care.
Methods
Genotyping
IL-6 KO mice was tested using genomic DNA and PCR
method to confirm deficiency of IL-6 gene as described
elsewhere [20, 21]. Briefly, ‘‘Genomic mini’’ kit (A&A
Biotechnology, Gdansk, Poland) was used to isolate
DNA from mouse tails followed by PCR [applied custom
made primers: F 50-AAGTGCATCATCGTTGTTCA
TAC30; R 50-CCATCCAGTTGCCTTCTTG-30 and com-
mercially available DNA polymerase Taq ‘‘Marathon’’
(A&A Biotechnology, Gdansk, Poland)]. Subsequently
DNA was separated on the 1 % agarose gel with ethi-
dium bromide by means of electrophoresis. As a result
we gained material from WT animals’ encompassed
DNA fragments with size ca. 900 bp, whereas DNA
fragments originate from knock-out mice (size about
1400 bp) additionally contained a fragment of neomycin
cassette.
Exercise Protocol
Animals were used after 7 days of acclimatization to the
laboratory conditions. They were maintained in a tem-
perature-controlled environment (22 ± 1 C) with a 12-h
light–dark cycles beginning at 7 a.m. Experiments took
place between 1.00 p.m. and 4.00 p.m. in the air-con-
ditioned, sound-isolated room with the possibility of an
accurate control of the light intensity. A single bout of
exercise was carried out in a tank consisted of a cir-
cular, galvanized and painted in white steel pool
(120 cm in diameter, 30 cm height) filled up to 26 cm
depth with water maintained at 30 ± 1 C. The mice
were submitted to swimming exercise carrying load
(lead fish sinkers, attached to the tail) corresponding to
5 % of their body weight. Animals were assessed to be
fatigued when they remained under the water surface for
5 s [16].
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Intramuscular FA (FAT/CD36, FABPpm, FATP-1,4),
Glucose (GLUT-1, GLUT-4) Transporters and pAMPK/
AMPK Protein Expression
The protein expression of FAT/CD36, FABPpm, FATP 1,
FATP 4 and GLUT-1, GLUT-4 (50 lg) as well as AMPK
and pAMPK (90 lg) was determined in muscle homoge-
nates (soleus). Western blotting technique was used to
detect the protein content as described by us and others [22,
23]. Briefly, the total protein content in each sample was
determined by bicinchoninic acid method with BSA serv-
ing as a protein standard. Then, the proteins in each sample
were separated using 10 % SDS-polyacrylamide gel elec-
trophoresis and transferred to the nitrocellulose membrane.
Equal protein concentrations were loaded in each lane as
confirmed by Ponceau staining the blot membrane. In the
next step membranes were immunoblotted with selected
primary antibodies (FAT/CD36, FATP 1, FATP 4 (Abcam,
EU) and GLUT-1, GLUT-4 and b-actin (Santa Cruz Bio-
technology, US) as well as AMPK, pAMPK (Thr172) (Cell
Signaling, US). Quantification of the selected protein
content was achieved by densitometry [Optical Density
(OD); Biorad, Poland]. The protein expression (FAT/
CD36, FATP 1, FATP 4, GLUT-1 and GLUT-4) was
related to b-actin and then to the control (WT sedentary or
IL-6 KO sedentary, appropriately as indicated in the leg-
ends of figures) that was set to 100 %. Finally, each
experimental group was expressed relatively (%) to the
control. In addition, AMPK activation was expressed as
pAMPK/AMPK ratio. Accordingly, Western Blots were
made in triplicates.
Intramuscular Lipid Content
The mice were killed by cervical dislocation and imme-
diately samples of soleus muscle were taken. Afterwards,
the samples were rapidly cleaned from any visible non-
muscle tissue, frozen in liquid nitrogen and finely pow-
dered. Next the powder was transferred to a glass tube for
consequent lipids extraction using the Folch et al. method
[24] with modifications of van der Vusse et al. [25]. Gas
liquid chromatography (Hewlett-Packard 5890 Series II gas
chromatograph, HP-INNOWax capillary column) was used
for identification and quantification of individual fatty acid
methyl esters, whereas the total FFA, TAG, DAG con-
centration was estimated as the sum of particular fatty acid
species content of the assessed fraction. The value was
expressed as nanomoles per gram of wet tissue.
Intramuscular Glycogen Content
Soleus glycogen content was determined as described
recently [23, 26]. Skeletal muscles were digested in 30 %
KOH for 20 min and then, a spectrophotometric assay was
used to qualify the content of free glucose. Glycogen level
is expressed in lmol of glucose/g of wet tissue.
Statistics
All data are expressed as means ± SEM. Statistical dif-
ferences between groups were tested with analysis of var-
iance (one way ANOVA) to determine the statistical
significance, and appropriate post hoc test. Statistical sig-
nificance was set at p B 0.05.
Results
Genotyping confirmed the deficiency of the functional IL-6
gene in the IL-6 KO mice as shown previously [20, 21].
IL-6 KO and wild type (WT) mice displayed no differences
in body weight and serum glucose or FFA levels (data not
shown, [21]).
Effect of IL-6 KO Genotype on Basal Skeletal Muscle
Fatty Acid Transporters Expression and Lipid Content
In sedentary groups, the expression of fatty acid trans-
porters (FAT/CD36: ?25 %; FABPpm: ?12.7 %; FATP-
1: ?31 %; p B 0.05; FATP-4: ?7.2 %; p [ 0.05) was
increased in muscles from IL-6 KO mice compared to wild
type mice (Fig. 1a–d). Accordingly intramuscular lipid
content was also increased in these muscles (FFA: ?38 %;
DAG: ?36 % and TAG: ?160 %; p B 0.05) (Fig. 2a, b).
Effect of IL-6 KO Genotype on Basal Skeletal Muscle
Glucose Transporters Expression and Glycogen
Content
Interestingly, IL-6 deficiency had only minor effect on: (1)
glucose transporters expression (GLUT-1: -4 %, and
GLUT-4: -5.1 %; p [ 0.05; Fig. 3a, b) and (2) glycogen
content in soleus muscle compared to control (-7 %;
p [ 0.05; Fig 3c).
Effect of Single Bout of Exhausting Exercise and IL-6
KO Genotype on Skeletal Muscle Fatty Acid
Transporters Expression and Lipid Content
A single bout of exhausting exercise induced a small but
significant increase in expression of both FAT/CD36 and
FATP-4 (?13 and ?10 %; p B 0.05; Fig. 4a), with no
apparent change in FABPpm and FATP-1 (?4.5 and
?2.5 %; p [ 0.05) in WT mice. No significant changes in
FA transporters expression induced by exercise were
observed in the IL-6 KO group (Fig. 4b).





















































































































































































80 kDa 40 kDa
63 kDa 70 kDa
-actin45 kDa 45 kDa -actin
-actin45 kDa 45 kDa -actin
Fig. 1 The effect of IL-6
deficiency on the expression of
fatty acid transporters (a FAT/
CD36, b FABPpm, c FATP-1,
d FATP-4) in soleus muscle of
sedentary mice. Representative
Western Blots present a relative
change in the protein expression
related to b-actin content.
(n = 8; asterisk WT Sed vs.
IL-6 KO Sed, P \ 0.05; OD
optical density; control
(WT Sed) set at 100 %)





































Fig. 2 The effect of IL-6
deficiency on intramuscular
lipid content (a FFA, DAG;
b TAG), in soleus muscle tissue
of sedentary mice. (n = 8;
asterisk WT Sed vs. IL-6 KO
Sed, P \ 0.05, FFA free fatty
acids, DAG diacylglycerols,
TAG triacylglycerols)
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Applied exercise induced a significant reduction in
intramuscular FFA and TAG content with more pro-
nounced depletion in IL-6 KO group (-30 and -50 % in
WT vs. -45 and -65 % in IL-6 KO group respectively;
p B 0.05; Fig. 5a, b). Apparently, not significant changes
were observed in DAG fraction in both groups studied
regardless the genotype.
Effect of Single Bout of Exhausting Exercise and IL-6
KO Genotype on Skeletal Muscle Glucose Transporters
Expression and Glycogen Content
Exercise induced a significant increase in glucose trans-
porters (GLUT-1: ?8 %, GLUT-4: ?15 %; p B 0.05;
Fig. 6a) in WT mice, with more pronounced changes in
IL-6 KO littermates (?20 and ?35 %; p B 0.05;
Fig. 6b).
In both WT and IL-6 KO mice, exhausting exercise
induced significant reduction in soleus muscle glycogen
level (-30 and 60 %, respectively; p B 0.05 Fig. 7a, b).
Effect of Single Bout of Exhausting Exercise and IL-6
KO Genotype on Skeletal Muscle AMPK Activation
Exercise-induced AMPK activation as shown by increased
the pAMPK/AMPK ratio (?40 %; p B 0.05; Fig. 8), but
only in WT mice, since we observed relatively lower
(-10 %; p [ 0.05; AMPK activation in IL-6 KO mice.
Effect of Single Bout of Exhausting Exercise and IL-6
KO Genotype on Time Performance of Exercise
IL-6 KO mice had a significantly reduced endurance
capacity compared to WT mice. The swimming duration






















































































































55 kDa 45 kDa
45 kDa -actin -actin45 kDa
Fig. 3 The effect of IL-6
deficiency on the expression of
glucose transporters (a GLUT-
1, b GLUT-4) in soleus muscle
of sedentary mice.
Representative Western Blots
present a relative change in the
protein expression related to
b-actin content. (n = 8; asterisk
WT Sed vs. IL-6 KO Sed,
P \ 0.05; OD optical density;
control (WT Sed) set at 100 %)
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comparing with WT littermates (95 min) (p B 0.05;
Fig. 9).
Discussion
The present study revealed that skeletal muscles from IL-6
deficient mice, when challenged by exercise, respond by:
(1) increased expression of glucose (mainly GLUT-4), but
not FA transporters and (2) increased reliance on intra-
muscular energy depots (-65 % TAG and -60 % glyco-
gen reductions). These are accompanied by a lack of
significant changes in the expression of AMPK kinase,
when compared to WT littermates. Along with the findings,
IL-6 KO mice displayed much shorter time till exhaustion



























































































































80 kD a 40 kDa 63 kDa 70 kDa
-actin45 kDa 45 kD a 45 kD a 45 kDa
-actin45 kD a 45 kD a 45 kD a 45 kDa
Fig. 4 The effect of a single bout of exhausting exercise on the
expression of fatty acid transporters (FAT/CD36, FABPpm, FATP-1,
FATP-4) in soleus muscle of WT (a) and IL-6 KO mice (b).
Representative Western Blots present a relative change in the protein
expression related to b-actin content. (n = 8; asterisk a WT Sed vs.
WT Ex, P \ 0.05; control (WT Sed) set at 100 %); asterisk b IL-6
KO Sed vs. IL-6 KO Ex, control (IL-6 KO Sed) set at 100 %)
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during intense swimming. We confirmed also our earlier
findings indicating a higher intramuscular lipid content
(TAG, FFA, DAG) together with greater FA transport
protein expression (FAT/CD36, FABPpm and FATP-1) in
IL-6 KO mice [21]. However, despite intramuscular lipid
accumulation and increased expression of FA transporters,
IL-6 KO mice displayed no other features of obese phe-
notype (as shown in our previous study) [21, 27].
A growing amount of evidence implicates IL-6 as an
important regulator of skeletal muscle metabolism. It
seems likely that interleukin-6 exerts its effect on glucose
uptake and FA oxidation in skeletal muscles via activation
of AMPK (AMP-activated protein kinase) [4, 28]. Studies
in vitro [29], ex vivo [30] and in vivo [31, 32] indicate a
direct link between IL-6 and AMPK activation. The present
study confirmed the existence of such a relations as evi-
denced by lower activation of AMPK during exercise in
IL-6 KO mice comparing to WT littermates. Therefore, we
may speculate also that, at rest, lack of functional IL-6
could significantly decreased basal AMPK activation,
which in turn, resulted in decreased FA oxidation and
subsequent accumulation of intramuscular lipids. This,
together with an increased fatty acid transporters expres-
sion in skeletal muscle, was likely the cause of fatty acids
accumulation in TAG and FFA fractions (present study and
[21]). Additionally, functional IL-6 deficiency when
challenged by exercise, induced a smaller reduction in
intramuscular lipids that, again, can be attributed to the
lack of significant AMPK activation (and AMPK-related
FA oxidation). Based on the above, we may speculate that
IL-6 deficiency diminishes the AMPK activation during
exercise and it seems likely, that exercise-induced activa-
tion of AMPK does not directly require IL-6 [33]. During
exercise IL-6 serum levels may be increased as much as
100-fold) [34, 35] and in WT mice greater AMPK activa-
tion results not only in a response to the increased ratio of
AMP/ATP but is additionally triggered by an IL-6 depen-
dent pathway [36]. An open question remains, whether
these effects are additive in skeletal muscles. Our findings
suggest such a possibility, since, in WT mice, exhausting
exercise induced not only a depletion of endogenous
energy stores (a reduction in TAG and glycogen), but also
induced glucose and fatty acid transporters expression,
exacerbating exogenous energy substrates flux into the
muscles. It is well known that AMPK activation results in
robust energy provision and many studies have shown
both: increased FA and glucose oxidation as well as
enhanced FA and glucose transporters expression [14, 37,
38]. The present study suggests that with IL-6 deficiency,
at least when AMPK activation is diminished, FA flux and
subsequent FA oxidation are reduced. Concomitantly, this



































































Fig. 5 The effect of a single
bout of exhausting exercise on
the fatty acid content (FFA,
DAG, TAG), in soleus muscle
of WT (a) and IL-6 KO mice
(b). (n = 8; asterisk WT vs. IL-
6 KO, P \ 0.05, FFA free fatty
acids, DAG diacylglycerols,
TAG triacylglycerols)
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exercise-induced AMPK activity, resulted in the increased
expression of GLUT-4. It leaves an open discussion for
other factors that may also be involved in favoring glucose
metabolism over FA oxidation. Furthermore, IL-6 deficient
animals exhibited diminished capacity for endurance per-
formance. Likely, it is related to the respiratory exchange
ratio (RER), since others reported that during exercise IL-6
KO mice reveal decreased exercise capacity [39]. Like-
wise, decreased AMPK activation (present study and [39])
could contribute to the shorter time till exhaustion as it was
shown in mice expressing a dominant negative AMPK
[40].
Along with this idea are studies showing that IL-6 may
play a significant role in angiogenesis processes [41]. Thus,
IL-6 deficiency may cause a decreased oxygen supply that
contributes to the decreased lipid utilization [42]. It has
also been suggested that IL-6 released from contracting
skeletal muscles stimulates the release of glucose and FA
from the liver and adipose tissue [1, 2] and lack of func-
tional IL-6 may result in a reduced plasma energy substrate
availability. We may speculate this may account for greater
reliance on intramuscular energy depots observed in IL-6
KO mice (a higher reduction of intramuscular glycogen
and TAG). Nevertheless, the exact mechanism responsible
for decreased endurance capacity in IL-6 deficient mice
needs to be clarified.
Summing up, the present study has provided several
novel findings. We confirmed greater expression of FA
transport proteins and accumulation of intramuscular lipids
in soleus from IL-6 KO sedentary mice. We found also that
IL-6 deficiency results in shorter time till exhaustion
accompanied by pronounced intramuscular glycogen
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Fig. 6 The effect of a single bout of exhausting exercise on the
expression of glucose transporters: GLUT-1, GLUT-4 in soleus
muscle of WT (a) and IL-6 KO mice (b). Representative Western
Blots present a relative change in the protein expression related to
b-actin content. (n = 8; asterisk a WT Sed vs. WT Ex, P \ 0.05;
control (WT Sed) set at 100 %); asterisk b IL-6 KO Sed vs IL-6 KO




WT Sed WT Ex
b IL-6 KO Sed IL-6 KO Ex
*
GLYCOGEN
Fig. 7 The effect of a single bout of exhausting exercise on the
glycogen content (lM of glucose/g of tissue) in soleus muscle of WT
(a) and IL-6 KO mice (b). (n = 8; asterisk a WT Sed vs. WT Ex and
b IL-6 KO Sed vs. IL-6 KO Ex, P \ 0.05)
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